Comparison of efficiency of high dose atorvastatin and endothelial progenitor-capture stents and bare metal stents in reduction of neointimal formation in patients with non ST-segment elevation acute coronary syndromes

Trial Profile

Comparison of efficiency of high dose atorvastatin and endothelial progenitor-capture stents and bare metal stents in reduction of neointimal formation in patients with non ST-segment elevation acute coronary syndromes

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Anti-CD34 monoclonal antibody (Primary) ; Atorvastatin
  • Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms JACK-EPC
  • Most Recent Events

    • 25 Sep 2010 Six-month results presented at the 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
    • 12 Apr 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology.
    • 23 Jan 2010 Clinical outcomes presented at Asia PCR/Singapore LIVE, according to an orbusneich media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top